{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ALKS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T04:46:57.602Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":3757,"canonical_name":"Alkermes plc.","cik":"0001520262","uei":null,"lei":null,"duns":null,"ticker":"ALKS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":57},"count":57,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-10-09","url_slug":"/sec/cik-0001520262/4/0001520262-26-000130","accession_number":"0001520262-26-000130","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-10-09","url_slug":"/sec/cik-0001520262/4/0001520262-26-000131","accession_number":"0001520262-26-000131","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-10-02","url_slug":"/sec/cik-0001520262/144/0001964306-26-000464","accession_number":"0001964306-26-000464","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-10-02","url_slug":"/sec/cik-0001520262/4/0001520262-26-000127","accession_number":"0001520262-26-000127","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-09-21","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-396065","accession_number":"0001193125-26-396065","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"3","title":"3 — Alkermes plc. — 2026-09-18","url_slug":"/sec/cik-0001520262/3/0001520262-26-000125","accession_number":"0001520262-26-000125","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-09-16","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-392527","accession_number":"0001193125-26-392527","importance":35},{"ts":"2026-09-03","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-09-03","url_slug":"/sec/cik-0001520262/144/0001964306-26-000424","accession_number":"0001964306-26-000424","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-09-03","url_slug":"/sec/cik-0001520262/4/0001520262-26-000120","accession_number":"0001520262-26-000120","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-09-01","url_slug":"/sec/cik-0001520262/144/0001964306-26-000417","accession_number":"0001964306-26-000417","importance":30},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-09-01","url_slug":"/sec/cik-0001520262/4/0001520262-26-000118","accession_number":"0001520262-26-000118","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-08-17","url_slug":"/sec/cik-0001520262/144/0001964306-26-000396","accession_number":"0001964306-26-000396","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-08-17","url_slug":"/sec/cik-0001520262/4/0001520262-26-000116","accession_number":"0001520262-26-000116","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-08-12","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-345901","accession_number":"0001193125-26-345901","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-08-07","url_slug":"/sec/cik-0001520262/4/0001520262-26-000113","accession_number":"0001520262-26-000113","importance":30},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"snyderman nancy lynn MD","title":null,"shares":44472,"price_per_share":50.348,"usd_value":2239076,"security_title":"Ordinary Shares","importance":37.239076256},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":9000,"price_per_share":48.58,"usd_value":437220,"security_title":"Ordinary Shares","importance":35.43722},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Gaffin David Joseph","title":"EVP, CLO, Alkermes, Inc.","shares":2034,"price_per_share":48.58,"usd_value":98812,"security_title":"Ordinary Shares","importance":35.09881172},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/144/0001964306-26-000350","accession_number":"0001964306-26-000350","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/144/0001964306-26-000351","accession_number":"0001964306-26-000351","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/144/0001964306-26-000352","accession_number":"0001964306-26-000352","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/4/0001520262-26-000109","accession_number":"0001520262-26-000109","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/4/0001520262-26-000110","accession_number":"0001520262-26-000110","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/4/0001520262-26-000111","accession_number":"0001520262-26-000111","importance":30},{"ts":"2026-08-03","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Alkermes plc. — 2026-08-03","url_slug":"/sec/cik-0001520262/8-k-a/0001193125-26-330564","accession_number":"0001193125-26-330564","importance":30},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"snyderman nancy lynn MD","title":null,"shares":27948,"price_per_share":46.72,"usd_value":1305731,"security_title":"Ordinary Shares","importance":16.30573056},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"snyderman nancy lynn MD","title":null,"shares":16524,"price_per_share":46.72,"usd_value":772001,"security_title":"Ordinary Shares","importance":15.77200128},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":4896,"price_per_share":24.59,"usd_value":120393,"security_title":"Ordinary Shares","importance":15.12039264},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":104,"price_per_share":19.34,"usd_value":2011,"security_title":"Ordinary Shares","importance":15.00201136},{"ts":"2026-07-28","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Alkermes plc. — 2026-07-28","url_slug":"/sec/cik-0001520262/10-q/0001193125-26-319022","accession_number":"0001193125-26-319022","importance":45},{"ts":"2026-07-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-07-28","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-318844","accession_number":"0001193125-26-318844","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"S-8","title":"S-8 — Alkermes plc. — 2026-07-28","url_slug":"/sec/cik-0001520262/s-8/0001193125-26-321193","accession_number":"0001193125-26-321193","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-07-08","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-298004","accession_number":"0001193125-26-298004","importance":35},{"ts":"2026-07-06","kind":"sec.form144","reporter":"Gaffin David Joseph","title":"Officer","shares":2034,"usd_value":109897,"security_title":"Common Stock","approx_sale_date":"2026-07-06","accession_number":"0001964306-26-000311","importance":40.021979404},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Gaffin David Joseph","title":"EVP, CLO, Alkermes, Inc.","shares":2034,"price_per_share":54.03,"usd_value":109897,"security_title":"Ordinary Shares","importance":35.10989702},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":8300,"price_per_share":51.4613,"usd_value":427129,"security_title":"Ordinary Shares","importance":35.42712879},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":700,"price_per_share":52.1314,"usd_value":36492,"security_title":"Ordinary Shares","importance":35.03649198},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-07-01","url_slug":"/sec/cik-0001520262/144/0001964306-26-000304","accession_number":"0001964306-26-000304","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-07-01","url_slug":"/sec/cik-0001520262/4/0001520262-26-000103","accession_number":"0001520262-26-000103","importance":30},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":5000,"price_per_share":19.34,"usd_value":96700,"security_title":"Ordinary Shares","importance":15.0967},{"ts":"2026-06-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-06-15","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-270280","accession_number":"0001193125-26-270280","importance":35},{"ts":"2026-06-12","kind":"sec.form144","reporter":"Wright Christopher I","title":"Officer","shares":2000,"usd_value":90200,"security_title":"Common Stock","approx_sale_date":"2026-06-12","accession_number":"0001964306-26-000282","importance":40.01804},{"ts":"2026-06-12","kind":"sec.insider.s","reporter":"Wright Christopher I","title":null,"shares":2000,"price_per_share":45.1,"usd_value":90200,"security_title":"Ordinary Shares","importance":35.0902},{"ts":"2026-06-12","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-06-12","url_slug":"/sec/cik-0001520262/144/0001964306-26-000282","accession_number":"0001964306-26-000282","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-06-12","url_slug":"/sec/cik-0001520262/4/0001520262-26-000101","accession_number":"0001520262-26-000101","importance":30},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Gaffin David Joseph","title":"EVP, CLO, Alkermes, Inc.","shares":2034,"price_per_share":43.05,"usd_value":87564,"security_title":"Ordinary Shares","importance":35.0875637},{"ts":"2026-06-04","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-06-04","url_slug":"/sec/cik-0001520262/144/0001964306-26-000268","accession_number":"0001964306-26-000268","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-06-04","url_slug":"/sec/cik-0001520262/4/0001520262-26-000099","accession_number":"0001520262-26-000099","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Hopkinson Craig C.","title":"Officer","shares":9000,"usd_value":375043,"security_title":"Ordinary shares","approx_sale_date":"2026-06-01","accession_number":"0001964306-26-000260","importance":40.075008646},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":9000,"price_per_share":41.6715,"usd_value":375044,"security_title":"Ordinary Shares","importance":35.3750435},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Alkermes plc. — 2026-06-01","url_slug":"/sec/cik-0001520262/144/0001964306-26-000260","accession_number":"0001964306-26-000260","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Alkermes plc. — 2026-06-01","url_slug":"/sec/cik-0001520262/4/0001520262-26-000097","accession_number":"0001520262-26-000097","importance":30},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Hopkinson Craig C.","title":"EVP R&D, Chief Medical Officer","shares":5000,"price_per_share":19.34,"usd_value":96700,"security_title":"Ordinary Shares","importance":15.0967},{"ts":"2026-05-20","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-05-20","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-232584","accession_number":"0001193125-26-232584","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Alkermes plc. — 2026-05-15","url_slug":"/sec/cik-0001520262/schedule-13g-a/0000080255-26-000390","accession_number":"0000080255-26-000390","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Alkermes plc. — 2026-05-13","url_slug":"/sec/cik-0001520262/defa14a/0001193125-26-221901","accession_number":"0001193125-26-221901","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Alkermes plc. — 2026-05-12","url_slug":"/sec/cik-0001520262/8-k/0001193125-26-218150","accession_number":"0001193125-26-218150","importance":35}]}